Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Eckerd v. Merck suit

Executive Summary

Firms settle antitrust suit filed by Jack Eckerd in Tampa Federal Court against Merck, challenging the manufacturer's single-price whslr./retailer policy. "The detailed provisions of the settlement are subject to a confidentiality agreement," the firms said in a joint Aug. 7 press release. The settlement does "not alter the prices and terms of sale by Merck to Eckerd, which are in accordance with Merck's publicly announced price lists." At the time of the suit's filing in 1982, the chain claimed that it would lose $900,000 in gross profits that fiscal year resulting from Merck's elimination of the 5% whslr. discount ("The Pink Sheet" April 12, 1982, p. 5).

You may also be interested in...



As Pandemic Boosts Demand For Immunity Supplements, Dentovations Launches Self+ Line

based firm, which markets Activa hand sanitizers, is offering Self+ immunity supplements in Brain, Energy and Unwind formulations in powder format for mixing with water.

Pink Sheet Podcast: The Big Vaccines Adcomm, AMAG Fights Makena Withdrawal

Pink Sheet reporters and editors discuss their take-aways from the recent advisory committee meeting on coronavirus vaccine development and approval, as well as the upcoming FDA hearing on Makena’s withdrawal.

Health And Wellness Trademark Review 20 October, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

UsernamePublicRestriction

Register

ID1132327

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel